{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:55:13Z","timestamp":1762505713748,"version":"3.41.2"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1111\/igc.0b013e31819c0f59","type":"journal-article","created":{"date-parts":[[2010,12,3]],"date-time":"2010-12-03T13:20:11Z","timestamp":1291382411000},"page":"245-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Clinical Outcome of ET-743 (Trabectedin; Yondelis) in High-Grade Uterine Sarcomas"],"prefix":"10.1016","volume":"19","author":[{"given":"Frederic","family":"Amant","sequence":"first","affiliation":[]},{"given":"An","family":"Coosemans","sequence":"additional","affiliation":[]},{"given":"Vincent","family":"Renard","sequence":"additional","affiliation":[]},{"given":"Els","family":"Everaert","sequence":"additional","affiliation":[]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1111\/IGC.0b013e31819c0f59_bb0005","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.2004.05.210","article-title":"Phase II study of Ectaneiscidin-743 in advanced soft tissue sarcoma patients","volume":"22","author":"Yovine","year":"2004","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0010","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1200\/JCO.2005.05.028","article-title":"Ectaneiscidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study","volume":"23","author":"Garcia-Carbonero","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0015","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1200\/JCO.2005.01.180","article-title":"Phase II study of ET-743 in advanced soft-tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft-tissue and bone sarcoma group trial","volume":"23","author":"Le Cesne","year":"2005","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0025","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.ygyno.2006.07.013","article-title":"Transition of endometrial stromal sarcoma into high grade sarcoma","volume":"103","author":"Amant","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0030","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2006.04.025","article-title":"Activity of trabectin (ET-743, Yondelis) in metastatic uterine leiomyosarcoma","volume":"102","author":"Tewari","year":"2006","journal-title":"Gynecol Oncol."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0035","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0959-8049(03)00458-1","article-title":"Phase I and pharmacokinetic study of Yondelis (Ectaneiscidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumors","volume":"39","author":"Twelves","year":"2003","journal-title":"Eur J Cancer."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/1097-0142(19830815)52:4<626::AID-CNCR2820520409>3.0.CO;2-E","article-title":"A randomized study of adriamycin with and without dimethyl triazinoimidazole carboxamide in advanced uterine sarcomas","volume":"52","author":"Omura","year":"1983","journal-title":"Cancer."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1438.1997.00451.x","article-title":"High-dose epirubicin in patients with advanced or recurrent uterine sarcoma","volume":"7","author":"Lissoni","year":"1997","journal-title":"Int J Gynecol Cancer."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0050","doi-asserted-by":"crossref","unstructured":"Sutton G, Blessing J, Barrett R, et al. Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1992;166:5 56-5 59.","DOI":"10.1016\/0002-9378(92)91671-V"},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0055","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1200\/JCO.2002.11.050","article-title":"Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial","volume":"20","author":"Hensley","year":"2002","journal-title":"J Clin Oncol."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0060","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ijc.21867","article-title":"Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: a retrospective analysis","volume":"119","author":"Bay","year":"2006","journal-title":"Int J Cancer."},{"key":"10.1111\/IGC.0b013e31819c0f59_bb0065","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1200\/JCO.2006.10.4117","article-title":"Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002","volume":"25","author":"Maki","year":"2007","journal-title":"J Clin Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2FIGC.0b013e31819c0f59","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2402677X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X2402677X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1111\/IGC.0b013e31819c0f59","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:16:58Z","timestamp":1753222618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X2402677X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S1048891X2402677X"],"URL":"https:\/\/doi.org\/10.1111\/igc.0b013e31819c0f59","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2009,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcome of ET-743 (Trabectedin; Yondelis) in High-Grade Uterine Sarcomas","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/IGC.0b013e31819c0f59","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}